Enochian BioSciences slumps after Hindenburg short report

Lunai Bioworks

01/06/2022 15:37

** Shares of Enochian BioSciences Inc  ENOB.O  plunge 38% to
$3.24 after Hindenburg Research releases short report 
    ** Gene therapy developer's stock hit an 18-month low last
week after Hindenburg shorted the stock
    ** ENOB's co-founder, Serhat Gumrukcu, was arrested by
Federal authorities over allegations that he conspired in a plot
to murder a Vermont father of six, Hindenburg said in a report
    ** With its founder and main source of scientific
discoveries jailed on murder-for-hire allegations, this
cash-burning company without peer-reviewed research and no
genuine clinical prospects is now a "catch me if you can" story
that we believe has finally reached the end-phase - Hindenburg 
    ** ENOB did not immediately respond to a Reuters request for
comment
    ** Shares set for worst session in nearly six years; down
55% YTD

 (Reporting by Sruthi Shankar and Susan Mathew)
 ((sruthi.shankar@thomsonreuters.com;))